A “roving band of feminists” organized by the National Women’s Liberation (NWL) took to the streets, or rather the aisles, in New York City Saturday to protest pharmacies that restrict over-the-counter access to Plan B One-Step.
NWL’s “Morning-After Pill Brigade” targeted five pharmacies near Union Square with an attention-getting, street-theater-style action that pointed out problems with Plan B accessibility to shoppers and management.
During the action, group leaders would loudly announce to the store that the brigade was looking for the morning-after pill. Group members then would disperse, asking where the emergency contraception was and handing shoppers a letter to the pharmacy’s CEO.
“The morning-after pill is locked in a box? You have to carry the box around the store?” protesters would say to each other. “Sure, so the whole store knows you had sex last night. That’s like wearing a dunce cap!”
Appreciate our work?
Vote now! And help Rewire earn a bigger grant from CREDO:
Indeed, many stores either keep Plan B behind the pharmacy counter, don’t stock more than two pills at a time, or keep the pill in a locked box that has to be opened by a store employee at the counter. Furthermore, employees are often confused about who has permission to open the box. NWL’s letter to pharmacy CEOs said that these store policies embarrass and shame women and restrict access.
NWL’s action alert for the protest showed a picture of locked-up Plan B pills, which cost about $50 each, sitting next to even more expensive digital ovulation kits that were not locked up. “You imply that women may steal [Plan B],” the letter to CEOs said.
At the New York action on Saturday, organizers told Rewire that Plan B was sold differently at pharmacies blocks away from each other.
One CVS had a paradoxical sign in the feminine care aisle directing shoppers to look for Plan B in the feminine care aisle; a manger threatened to call the police when organizers demanded more information. A Rite Aid had the pill in a locked box.
Two Duane Reades and a Walgreens, meanwhile, had newer plastic packaging that didn’t require unlocking a box, which organizers said they hadn’t seen before and were encouraged by. NWL organizer Erin Mahoney had previously argued with the managers of one pharmacy that had the newer packaging this time around.
“We will continue to target pharmacies whenever and wherever we see obstructions to women’s access,” NWL coordinator Annie Tummino told Rewire in an email.
But NWL organizers aren’t done fighting. A Food and Drug Administration ruling that only one brand of emergency contraception, Plan B, could be sold over-the-counter means that less expensive generic pills are still restricted to behind the counter.
“We want to bring up that [lack of pharmacy access] isn’t the only obstacle, that price really gets in the way of women being able to get the morning-after pill,” said NWL organizer Brooke Eliazar-Macke.
Today, women are able to access emergency contraception, a safe, second-chance option for preventing unintended pregnancy in a timely manner without a prescription. Clinton helped make this happen, and I can tell the story from having watched it unfold.
In the midst of election-year talk and debates about political controversies, we often forget examples of candidates’ past leadership. But we must not overlook the ways in which Hillary Clinton demonstrated her commitment to women’s health before she became the Democratic presidential nominee. In early 2008, I wrote the following article for Rewire—which has been lightly edited—from my perspective as a former official at the U.S. Food and Drug Administration (FDA) about the critical role that Clinton, then a senator, had played in making the emergency contraception method Plan B available over the counter. She demanded that reproductive health benefits and the best available science drive decisions at the FDA, not politics. She challenged the Bush administration and pushed the Democratic-controlled Senate to protect the FDA’s decision makingfrom political interference in order to help women get access to EC.
Since that time, Plan B and other emergency contraception pills have become fully over the counter with no age or ID requirements. Despite all the controversy, women at risk of unintended pregnancy finally can get timely access to another method of contraception if they need it—such as in cases of condom failure or sexual assault. By 2010, according to National Center for Health Statistics data, 11 percent of all sexually experienced women ages 15 to 44 had ever used EC, compared with only 4 percent in 2002. Indeed, nearly one-quarter of all women ages 20 to 24 had used emergency contraception by 2010.
As I stated in 2008, “All those who benefited from this decision should know it may not have happened were it not for Hillary Clinton.”
Now, there are new emergency contraceptive pills (Ella) available by prescription, women have access to insurance coverage of contraception without cost-sharing, and there is progress in making some regular contraceptive pills available over the counter, without prescription. Yet extreme calls for defunding Planned Parenthood, the costs and lack of coverage of over-the-counter EC, and refusals by some pharmacies to stock emergency contraception clearly demonstrate that politicization of science and limits to our access to contraception remain a serious problem.
Appreciate our work?
Vote now! And help Rewire earn a bigger grant from CREDO:
Today, women are able to access emergency contraception, a safe, second chance option for preventing unintended pregnancy in a timely manner without a prescription. Sen. Hillary Clinton (D-NY) helped make this happen, and I can tell the story from having watched it unfold.
Although stories about reproductive health and politicization of science have made headlines recently, stories of how these problems are solved are less often told. On August 31, 2005 I resigned my position as assistant commissioner for women’s health at the Food and Drug Administration (FDA) because the agency was not allowed to make its decisions based on the science or in the best interests of the public’s health. While my resignation was widely covered by the media, it would have been a hollow gesture were there not leaders in Congress who stepped in and demanded more accountability from the FDA.
I have been working to improve health care for women and families in the United States for nearly 20 years. In 2000, I became the director of women’s health for the FDA. I was rather quietly doing my job when the debate began in 2003 over whether or not emergency contraception should be provided over the counter (OTC). As a scientist, I knew the facts showed that this medication, which can be used after a rape or other emergency situations, prevents an unwanted pregnancy. It does not cause an abortion, but can help prevent the need for one. But it only works if used within 72 hours, and sooner is even better. Since it is completely safe, and many women find it impossible to get a doctor’s appointment within two to three days, making emergency contraception available to women without a prescription was simply the right thing to do. As an FDA employee, I knew it should have been a routine approval within the agency.
Plan B emergency contraception is just like birth control pills—it is not the “abortion pill,” RU-486, and most people in the United States don’t think access to safe and effective contraception is controversial. Sadly, in Congress and in the White House, there are many people who do oppose birth control. And although this may surprise you, this false “controversy” not only has affected emergency contraception, but also caused the recent dramatic increase in the cost of birth control pills on college campuses, and limited family planning services across the country. The reality is that having more options for contraception helps each of us make our own decisions in planning our families and preventing unwanted pregnancies. This is something we can all agree on.
Meanwhile, inside the walls of the FDA in 2003 and 2004, the Bush administration continued to throw roadblocks at efforts to approve emergency contraception over the counter. When this struggle became public, I was struck by the leadership that Hillary Clinton displayed. She used the tools of a U.S. senator and fought ardently to preserve the FDA’s independent scientific decision-making authority. Many other senators and congressmen agreed, but she was the one who took the lead, saying she simply wanted the FDA to be able to make decisions based on its public health mission and on the medical evidence.
When it became clear that FDA scientists would continue to be overruled for non-scientific reasons, I resigned in protest in late 2005. I was interviewed by news media for months and traveled around the country hoping that many would stand up and demand that FDA do its job properly. But, although it can help, all the media in the world can’t make Congress or a president do the right thing.
Sen. Clinton made the difference. The FDA suddenly announced it would approve emergency contraception for use without a prescription for women ages 18 and older—one day before FDA officials were to face a determined Sen. Clinton and her colleague Sen. Murray (D-WA) at a Senate hearing in 2006. No one was more surprised than I was. All those who benefited from this decision should know it may not have happened were it not for Hillary Clinton.
Sometimes these success stories get lost in the “horse-race stories” about political campaigns and the exposes of taxpayer-funded bridges to nowhere, and who said what to whom. This story of emergency contraception at the FDA is just one story of many. Sen. Clinton saw a problem that affected people’s lives. She then stood up to the challenge and worked to solve it.
The challenges we face in health care, our economy, global climate change, and issues of war and peace, need to be tackled with experience, skills and the commitment to using the best available science and evidence to make the best possible policy. This will benefit us all.
With the recent U.S. Supreme Court ruling, change may be afoot—even in some of the reddest red states. But anti-choice laws are still wreaking havoc around the world, like in Northern Ireland where women living under an abortion ban are turning to drones for medication abortion pills.
Welcome to Gavel Drop, our roundup of legal news, headlines, and head-shaking moments in the courts.
The New York Times published a map explaining how the U.S. Supreme Court’s ruling in Whole Woman’s Health v. Hellerstedt could affect abortion nationwide.
The Supreme Court vacated the corruption conviction of “Governor Ultrasound:” Former Virginia Gov. Bob McDonnell, who signed a 2012 bill requiring women get unnecessary transvaginal ultrasounds before abortion.
Had Justice Antonin Scalia been alive, explains Emma Green for the Atlantic, there would have been the necessary fourth vote for the Supreme Court to take a case about pharmacists who have religious objections to doing their job when it comes to providing emergency contraception.